Evidence map›Paper›PMID 40195214›Full record

ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2025

Elucidation of the mechanism of precipitate formation on mixing nafamostat mesylate solution with dialysate.

Iori Okamoto, Koichiro Oji, Otoka Nakashima, Yoka Shu, Hisatsugu Takahara, Hitoshi Suzuki, Hitoshi Muguruma

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Iori OkamotoDepartment of Clinical Engineering, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 279-0021, Japan.
Koichiro OjiDepartment of Clinical Engineering, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 279-0021, Japan.
Otoka NakashimaFaculty of Medical Science, Juntendo University, 6-8-1 Hinode, Urayasu, Chiba, 279-0013, Japan.
Yoka ShuFaculty of Medical Science, Juntendo University, 6-8-1 Hinode, Urayasu, Chiba, 279-0013, Japan.
Hisatsugu TakaharaDepartment of Nephrology and Hypertension, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 279-0021, Japan.
Hitoshi SuzukiDepartment of Nephrology and Hypertension, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 279-0021, Japan.
Hitoshi MugurumaFaculty of Medical Science, Juntendo University, 6-8-1 Hinode, Urayasu, Chiba, 279-0013, Japan. h.muguruma.xj@juntendo.ac.jp.ORCID http://orcid.org/0000-0001-5213-2062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study clarifies the reagent preparation and administration conditions that lead to precipitation when nafamostat mesylate salt (NM) solution is mixed with dialysate. The objective is to elucidate the mechanism of precipitation. It was observed that the Carbostar

Indexed as

Chemical PrecipitationDialysis SolutionsGuanidinesRenal DialysisBenzamidinesHydrogen-Ion ConcentrationSolubilityBenzamidinesDialysis SolutionsGuanidinesnafamostatBicarbonate ionDialysateNafamostat mesylatePoorly soluble salt

Identifiers

PMID40195214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.